Myotonic dystrophy type 1 presenting with dyspnea: A case report

被引:1
作者
Jia, Yu-Xi [1 ,2 ]
Dong, Chun-Ling [3 ]
Xue, Jia-Wei [3 ]
Duan, Xiao-Qin [4 ]
Xu, Ming-Yu [3 ]
Su, Xiao-Min [3 ]
Li, Ping [5 ,6 ]
机构
[1] Jilin Univ, Dept Orthoped, Hosp 2, Changchun 130041, Jilin, Peoples R China
[2] Jilin Univ, Applicat Demonstrat Ctr Precis Med Mol Diag, Hosp 2, Changchun 130041, Jilin, Peoples R China
[3] Jilin Univ, Dept Resp & Crit Care Med, Hosp 2, Changchun 130041, Jilin, Peoples R China
[4] Jilin Univ, Dept Rehabil Med, Hosp 2, Changchun 130041, Jilin, Peoples R China
[5] Jilin Univ, Dept Dev Pediat, Hosp 2, Changchun 130041, Jilin, Peoples R China
[6] Jilin Univ, Dept Dev Pediat, Hosp 2, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China
关键词
Myotonic dystrophy type 1; DMPK gene; Respiratory insufficiency; Sleep apnea; Non-invasive ventilation; PREVALENCE; MORTALITY; COHORT;
D O I
10.12998/wjcc.v10.i20.7060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Myotonic dystrophy type 1 (DM1) is a genetic neuromuscular disease involving multiple systems, especially the cardiopulmonary system. The clinical phenotype of DM1 patients is highly variable, which limits early diagnosis and treatment. In the present study, we reported a 35-year-old female DM1 patient with dyspnea as the primary onset clinical manifestation, analyzed her family's medical history, and reviewed related literature. CASE SUMMARY A 35-year-old woman was admitted to the hospital with dyspnea of 1 mo duration, and sleep apnea for 3 d. Her respiratory pattern and effort were normal, but limb muscle tension was low. Investigation into the patient's medical history revealed that she might have hereditary neuromuscular disease. Electromyography showed that her myotonia potentials were visible in the resting state of the examined muscles, with decreased motor unit potential time limit and amplitude. Genetic testing for DM1 revealed that the cytosine-thymine-guanine (CTG) repeat number of the DMPK gene exceeded 50, while cytosine-CTG expansion in intron 1 of ZNF9 gene was < 30 repeats. The patient was diagnosed with DM1. CONCLUSION DM1 is a genetic neuromuscular disease involving multiple systems, and the clinical phenotype in DM1 is extremely variable. Some patients with DM1 may be presented at the respiratory department because of dyspnea, which should be cautioned by the pulmonologists. There may be no obvious or specific symptoms in the early stage of disease, and clinicians should improve their understanding of DM1 and make an early diagnosis, which will improve patients' quality of life.
引用
收藏
页码:7060 / 7067
页数:8
相关论文
共 26 条
  • [1] Ahmad S., 2021, EUR HEART J-CASE REP, V5, pytab409
  • [2] Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions
    Arsenault, ME
    Prévost, C
    Lescault, A
    Laberge, C
    Puymirat, J
    Mathieu, J
    [J]. NEUROLOGY, 2006, 66 (08) : 1248 - 1250
  • [3] The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1
    Batra, Ranjan
    Nelles, David A.
    Roth, Daniela M.
    Krach, Florian
    Nutter, Curtis A.
    Tadokoro, Takahiro
    Thomas, James D.
    Sznajder, Lukasz J.
    Blue, Steven M.
    Gutierrez, Haydee L.
    Liu, Patrick
    Aigner, Stefan
    Platoshyn, Oleksandr
    Miyanohara, Atsushi
    Marsala, Martin
    Swanson, Maurice S.
    Yeo, Gene W.
    [J]. NATURE BIOMEDICAL ENGINEERING, 2021, 5 (02) : 157 - 168
  • [4] Transcriptionally correlated subcellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of myotonic dystrophy type 1
    Coleman, Stewart M.
    Prescott, Alan R.
    Sleeman, Judith E.
    [J]. BIOCHEMICAL JOURNAL, 2014, 458 : 267 - 280
  • [5] Dauvilliers Yves A, 2012, Sleep Med Rev, V16, P539, DOI 10.1016/j.smrv.2012.01.001
  • [6] AN UNSTABLE TRIPLET REPEAT IN A GENE RELATED TO MYOTONIC MUSCULAR-DYSTROPHY
    FU, YH
    PIZZUTI, A
    FENWICK, RG
    KING, J
    RAJNARAYAN, S
    DUNNE, PW
    DUBEL, J
    NASSER, GA
    ASHIZAWA, T
    DEJONG, P
    WIERINGA, B
    KORNELUK, R
    PERRYMAN, MB
    EPSTEIN, HF
    CASKEY, CT
    [J]. SCIENCE, 1992, 255 (5049) : 1256 - 1258
  • [7] Targeting Myotonic Dystrophy Type 1 with Metformin
    Garcia-Puga, Mikel
    Saenz-Antonanzas, Ander
    Matheu, Ander
    Lopez de Munain, Adolfo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [8] Importance of three-dimensional speckle tracking in the assessment of left atrial and ventricular dysfunction in patients with myotonic dystrophy type 1
    Guedes, Henrique
    Moreno, Nuno
    dos Santos, Rui Pontes
    Marques, Leonor
    Seabra, Daniel
    Pereira, Adriana
    Andrade, Aurora
    Pinto, Paula
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (04) : 333 - 338
  • [9] High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2
    Hilbert, James E.
    Barohn, Richard J.
    Clemens, Paula R.
    Luebbe, Elizabeth A.
    Martens, William B.
    McDermott, Michael P.
    Parkhill, Amy L.
    Tawil, Rabi
    Thornton, Charles A.
    Moxley, Richard T., III
    [J]. NEUROLOGY, 2017, 89 (13) : 1348 - 1354
  • [10] Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
    Logigian, E. L.
    Martens, W. B.
    Moxley, R. T.
    McDermott, M. P.
    Dilek, N.
    Wiegner, A. W.
    Pearson, A. T.
    Barbieri, C. A.
    Annis, C. L.
    Thornton, C. A.
    Moxley, R. T., III
    [J]. NEUROLOGY, 2010, 74 (18) : 1441 - 1448